Cargando…
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies, surgery and radiotherapy represent the primary treatment options for most patients. But these treatments are associated with...
Autores principales: | Alsahafi, Elham, Begg, Katheryn, Amelio, Ivano, Raulf, Nina, Lucarelli, Philippe, Sauter, Thomas, Tavassoli, Mahvash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629629/ https://www.ncbi.nlm.nih.gov/pubmed/31308358 http://dx.doi.org/10.1038/s41419-019-1769-9 |
Ejemplares similares
-
Inside the hypoxic tumour: reprogramming of the DDR and radioresistance
por: Begg, Katheryn, et al.
Publicado: (2020) -
MicroRNA‐9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4
por: Hersi, Hersi Mohamed, et al.
Publicado: (2018) -
Clinical update on cancer: molecular oncology of head and neck cancer
por: Suh, Y, et al.
Publicado: (2014) -
EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma
por: Nantajit, Danupon, et al.
Publicado: (2022) -
Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer
por: Codony, Victoria L., et al.
Publicado: (2021)